NEW YORK, NY / ACCESSWIRE / November 10, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Walter Investment Management Corp (NYSE: WAC), MYR Group Inc (NASDAQ: MYRG), Covenant Transportation Group Inc (NASDAQ: CVTI) and CytomX Therapeutics Inc (NASDAQ: CTMX). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
============
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
WAC Research Package: http://www.traders-choice.com/pdf?s=WAC
MYRG Research Package: http://www.traders-choice.com/pdf?s=MYRG
CVTI Research Package: http://www.traders-choice.com/pdf?s=CVTI
CTMX Research Package: http://www.traders-choice.com/pdf?s=CTMX
============
Highlights from today's reports include:
On Monday, November 09, 2015, NASDAQ ended at 5,095.30, down 1.01%, Dow Jones declined 1.00%, to finish the day at 17,730.48, and the S&P closed at 2,078.58, down 0.98%.
- Walter Investment Management Corp's stock added 8.78% to close Monday's session at USD 11.52. The company's shares oscillated between USD 10.66 and USD 11.70. The stock recorded a trading volume of 0.39 million shares, which was above its 50-day daily average volume of 0.18 million shares and above its 52-week average volume of 0.31 million shares. Over the last five days, Walter Investment Management Corp's shares have declined by 10.49% and in the past one month, it has lost 32.12%. In addition, over the last three months, the stock has lost 34.13% and year to date, the shares have shed 30.22%. Further, the stock is trading at a price to cash flow ratio of 38.93 and price to sales ratio of 29.90. The company has a market capitalization of USD 435.5 million. The last traded price of the stock was above the 50-Day Moving Average of USD 15.43 while the same is below the 200-Day Moving Average of USD 17.78.
- MYR Group Inc's stock advanced 0.05% to close Monday's session at USD 19.42. The share price vacillated between USD 19.19 and USD 19.57. The stock recorded a trading volume of 0.24 million shares, which was above its 50-day daily average volume of 0.19 million shares and above its 52-week average volume of 0.15 million shares. Over the last three days, MYR Group Inc's shares have declined by 14.07% and in the past one week it has moved down 15.97%. Moreover, in the last six months, the stock has lost 35.31% and year to date, the shares have shed 29.12%. Further, the company is trading at a price to earnings ratio of 11.63 and a price to book ratio of 1.18. This compares to a historical PE ratio of 16.22 and the historical PB ratio close to 1.77. Additionally, the stock is trading at a price to cash flow ratio of 5.12 and price to sales ratio of 0.38.
- Covenant Transportation Group Inc's stock edged lower by 6.35% to close Monday's session at USD 20.49. The company's shares oscillated between USD 20.29 and USD 21.80. The stock recorded a trading volume of 0.12 million shares, which was below its 50-day daily average volume of 0.18 million shares and below its 52-week average volume of 0.24 million shares. Over the last three days, Covenant Transportation Group Inc's shares have advanced 2.86% and in the past one week it has moved up 1.99%. Furthermore, over the last three months, the stock has lost 20.46% and in the past six months, the shares have shed 36.62%. The company is trading at a price to earnings ratio of 8.54 and a price to book ratio of 2.04. This compares to a historical PE ratio of 23.57 and the historical PB ratio close to 2.90. Additionally, the stock is trading at a price to cash flow ratio of 3.74 and price to sales ratio of 0.48.
- The stock of CytomX Therapeutics Inc gained 7.36% to close Monday's session at USD 12.26. The shares of the company moved in the range of USD 11.20 and USD 12.87. The 52-week trading range of the stock is between USD 9.01 and USD 17.02. A trading volume of 0.04 million shares was recorded, below its 52-week average volume of 0.10 million shares. Over the last five days, CytomX Therapeutics Inc's shares have advanced 9.56% and in the past one month, it has lost 4.96%. Further, the company is trading at a price to book ratio of 6.7, price to cash flow ratio of 6.7 and price to sales ratio of 26.5. The company has a market capitalization of USD 428.2 million. The stock is currently trading 9.96%, 9.37%, and 9.37%, above its 20-day simple moving average, 50-day simple moving average and 200-day simple moving average, respectively.
--
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the 'Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice